Stock Fundamentals

Company Information

Company Name
Connect Biopharma Holdings Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US2075231017
CIK: 0001835268
CUSIP: 207523101
Currency: USD
Full Time Employees: 64
Phone: 877 245 2787
Fiscal Year End: December
IPO Date: Mar 19, 2021
Description:

Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.

Address:

3580 Carmel Mountain Road, San Diego, CA, United States, 92130

Directors & Officers

Name Title Year Born
Dr. Barry D. Quart Pharm.D. CEO & Director 1957
Mr. David L. Szekeres J.D. President 1974
Ms. Lisa Peraza CPA Senior Vice President of Finance 1977
Mr. Jeff Cohn J.D. General Counsel & Corporate Secretary 1982
Mr. Sean T. Ristine Vice President of Human Resources 1970
Dr. Lei Sun Ph.D. VP of Biologics & Head of CMC 1964
Dr. Srikanth Pendyala M.D. Senior Vice President of Clinical Development(Consultant) NA
Ms. Kimberly J. Manhard Executive VP & Chief Development Officer 1960

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 31, 2026 James Huang N/A Purchase 1.16M $3.45 $4.00M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
EverSource Wealth Advisors, LLC 1.25K Mar 31, 2026 0.00% $0.00 -3.18%

Shares Statistics

Shares Outstanding: 62.96M
Shares Float: 18.86M
% Insiders: 3,182.40%
% Institutions: 5,426.20%
Short % Float: 2.63%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Nasdaq Composite Index 23.32K 0.04% ▲ 0.00% Jul 31, 2025

Valuation Metrics

Enterprise Value: $88.14M
Trailing P/E: 0.00
Forward P/E: 0.77

Financial Highlights

Market Cap: $133.48M
EBITDA: $-65.54M
Book Value: $0.68
Earnings/Share: $-1.15
Profit Margin: 0.00%
Operating Margin: -11,601.78%
ROA (TTM): -54.20%
ROE (TTM): -102.94%
Revenue (TTM): $233.00K
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 3.74x 0.01x 0.25x N/A -0.01x
2024-12-31 11.46x 0.00x 0.09x N/A -0.01x
2023-12-31 4.85x 0.00x 0.20x -3,002.43x 0.00x
2022-12-31 9.97x 0.00x 0.09x -5,673.07x 0.00x
2021-12-31 15.30x 0.00x 0.06x -14,199.60x 0.00x
2020-12-31 27.81x 0.00x 1.94x -4,708.64x 0.00x
2019-12-31 13.24x 0.00x 1.80x -2,080.02x 0.00x
2018-12-31 70.44x 0.00x 1.28x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CNTB.US!